Oh no @peterkins22 another phase 1 trial
I copied this from the poster - they sure have loaded the study up with a whopping 4 patients
"....Within patients treated at dose level 1, a disease control rate of 75% was shown as three out of the four patients treated achieved a best response of stable disease assessed by RANO(response assessment in neuro-oncology)....."
BTW hope you had a great weekend the data releases for Kazia's many trials edge ever closer - did you sell all your Kazia holding?
- Forums
- ASX - By Stock
- The 3rd Glioblastoma Drug Development Summit
Oh no @peterkins22 another phase 1 trial ;) I copied this from...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)